The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Averback Paul since 2018.
The trader's CIK number is 1569706.
At the time of the last reporting, Averback Paul was the CEO of Nymox Pharmaceutical Corp. (stock ticker symbol NYMX).
Also see all insider trading activities at Nymox Pharmaceutical Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | NYMX | 0 | $0 | 1,787,600 | $4,394,000 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-29 | NYMX | Sale | 1,687,600 | 2.50 | 4,219,000 |
| 2018-10-26 | NYMX | Sale | 100,000 | 1.75 | 175,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Averback Paul (CEO of Nymox Pharmaceutical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.